In vitro developmental toxicology assays: A review of the state of the science of rodent and zebrafish whole embryo culture and embryonic stem cell assays

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 90, Issue 2, 2010, Pages 87-98

  Augustine Rauch, Karen ^a   Zhang, Cindy X ^a   Panzica Kelly, Julieta M ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; ENDOTHELIN RECEPTOR ANTAGONIST; ETHYLNITROSOUREA; MYOSIN;

BREEDING; CARTILAGE CELL; CELL ADHESION; CELL AGGREGATION; CELL ASSAY; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CHORION; CONGENITAL MALFORMATION; CULTURE MEDIUM; CYTOTOXICITY; DEVELOPMENTAL BIOLOGY; DEVELOPMENTAL GENETICS; DEVELOPMENTAL STAGE; DISEASE SEVERITY; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYO GROWTH; EMBRYONIC STEM CELL; EMBRYOTOXICITY; FALSE POSITIVE RESULT; FERTILIZATION IN VITRO; FLOW CYTOMETRY; GASTRULATION; GENE EXPRESSION; GENE MAPPING; GENOME; HAPLOIDY; HEART MUSCLE CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LARVA; LIMB BUD; MICROARRAY ANALYSIS; MUTAGENESIS; NERVE CELL; NIDATION; NONHUMAN; ORGANOGENESIS; OSTEOBLAST; OUTCOME ASSESSMENT; PHARYNX; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RODENT; TERATOGENICITY; VALIDATION STUDY; YOLK SAC; ZEBRA FISH;

ANIMALS; EMBRYO, NONMAMMALIAN; EMBRYONIC STEM CELLS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; RATS; RESEARCH; RODENTIA; TERATOGENS; ZEBRAFISH;

ANIMALIA; DANIO RERIO; RATTUS; RODENTIA;

EID: 77953521553     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.20175     Document Type: Review

References (50)

1. Asada H, Kawamura Y, Maruyama K, et al. 1997. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 94: 6496-6499.
2. Augustine-Rauch KA, Zhang Q, Kleinman M, et al. 2004. A study of vehicles for dosing rodent whole embryo culture with non aqueous soluble compounds. Reprod Toxicol 18:391-398.
3. Augustine KA. 2009. HESI DART. Alternative assays workshop II: Generation and preliminary assessment of a zebrafish teratogenicity assay. Available at http://www.hesiglobal.org/i4a/pages/index.cfm?pageID53333. European Teratology Society.
4. Bournias-Vardiabasis N, Teplitz RL. 1982. Use of Drosophila embryo cell cultures as an in vitro teratogen assay. Teratogen Carcinogen Mutagen 2:333-341.
5. Brannen KC, Panzica-Kelly JM, Danberry TL, Augustine-Rauch KA. 2010. Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. Birth Defects Res 89:66-77.
6. Brannen KC, Panzica-Kelly J, Charlap JH, Augustine-Rauch K. 2008. Zebrafish: A nonmammalian model of developmental toxicology. In: Hansen DK, Abbott BD, editors. Developmental toxicology. 3rd ed. New York: Informa Healthcare. pp.215-241.
7. Brown NA, Fabro S. 1981. Quantitation of rat embryonic development in vitro: A morphological scoring system. Teratology 24:65-78. (Pubitemid 12175437)
8. Chapin R, Augustine-Rauch K, Beyer B, et al. 2008. State of the art in developmental toxicity screening methods and a way forward: A meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish. Birth Defects Res 83:446-456.
9. Cicurel L, Schmid BP. 1988. Postimplantation embryo culture for the assessment of the teratogenic potential and potency of compounds. Experientia 44:833-840.
10. Cockroft DL. 1988. Changes with gestational age in the nutritional requirements of postimplantation rat embryos in culture. Teratology 38: 281-290.
11. Driever W, Solnica-Krezel L, Schier AF, et al. 1996. A genetic screen for mutations affecting embryogenesis in zebrafish. Development 123:37-46. (Pubitemid 27056734)
12. Ellington SK. 1983. Effects of calcium on the growth of the rat conceptus during organogenesis in vitro. J Reprod Fertil 67:327-334.
13. Ellington SK. 1987. In vitro analysis of glucose metabolism and embryonic growth in postimplantation rat embryos. Development 100:431-439.
14. Festag M, Viertel B, Steinberg P, Sehner C. 2007. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds. Toxicol In Vitro 21:1631-1640.
15. Fort DJ, Rogers RL, Thomas JH, et al. 2004. Comparative sensitivity of Xenopus tropicalis and Xenopus laevis as test species for the FETAX model. J Appl Toxicol 24:443-457.
16. Fort DJ, Stover EL, Bantle JA, et al. 1998. Phase III interlaboratory study of FETAX, Part 2: Interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay-Xenopus (FETAX). Drug Chem Toxicol 21:1-14.
17. Franklin AW. 1962. Thalidomide babies. Memorandum from the British paediatric association. British Med J 2:522-524.
18. Fujinaga M, Mazze RI, Baden JM, et al. 1988. Rat whole embryo culture: An in vitro model for testing nitrous oxide teratogenicity. Anesthesiology 69:401-404.
19. Genschow E, Spielmann H, Scholz G, et al. 2004. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 32:209-244. (Pubitemid 39517737)
20. Genschow E, Spielmann H, Scholz G, et al. 2002. The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European centre for the validation of alternative methods. Altern Lab Anim 30:151-176.
21. Gillis L. 1962. Thalidomide babies: Management of limb defects. British Med J 2:647-651.
22. Haffter P, Granato M, Brand M, et al. 1996. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123:1-36.
23. Hunter ES III, Sadler TW, Wynn RE. 1987. A potential mechanism of DL-beta- hydroxybutyrate-induced malformations in mouse embryos. Am J Physiol 253(1 Part 1):E72-E80.
24. Knaut H, Steinbeisser H, Schwarz H, Nusslein-Volhard C. 2002. An evolutionary conserved region in the vasa 30UTR targets RNA translation to the germ cells in the zebrafish. Curr Biol 12:454-466.
25. Lenz W, Knapp K. 1962. Thalidomide embryopathy. Archives Environ Health 5:100-105.
26. Lilienblum W, Dekant W, Foth H, et al. 2008. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH). Archives Toxicol 82:211-236.
27. McGrath P, Li CQ. 2008. Zebrafish: A predictive model for assessing drug-induced toxicity. Drug Disc Today 13:394-401.
28. Nagel R. 2002. DarT: The embryo test with the Zebrafish Danio rerio-A general model in ecotoxicology and toxicology. Altex 19(Suppl 1):38-48.
29. New DA. 1978. Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol Rev Cambridge Philosophical Soc 53: 81-122.
30. New DA. 1983. In vitro culture of embryo and fetus. Proc Ann Symp Eugenics Soc 19:163-176.
31. Panzica-Kelly JM, Zhang CX, Danberry TL et al. Morphological score assignment guidelines for the dechorionated zebrafish teratogenicity assay. Abstract 27. 2010 BDRA (88), p 361.
32. Parng C, Seng WL, Semino C, McGrath P. 2002. Zebrafish: A preclinical model for drug screening. Assay and drug development technologies 1(1 Part 1):41-48.
33. Raabe M, Flynn LM, Zlot CH, Wong JS, et al. 1998. Knockout of the abetalipoproteinemia gene in mice: Reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc Natl Acad Sci USA 95:8686-8691.
34. Sadler TW, Horton WE, Warner CW. 1982. Whole embryo culture: A screening technique for teratogens? Teratogen Carcinogen Mutagen 2: 243-253.
35. Schmid BP, Goulding E, Kitchin K, Sanyal MK. 1981. Assessment of the teratogenic potential of acrolein and cyclophosphamide in a rat embryo culture system. Toxicology 22:235-243.
36. Schmid BP, Trippmacher A, Bianchi A. 1983. Validation of the whole-embryo culture method for in vitro teratogenicity testing. Develop Toxicol Environ Sci 11:563-566.
37. Scholz S, Fischer S, Gundel U, et al. 2008. The zebrafish embryo model in environmental risk assessment- applications beyond acute toxicity testing. Environ Sci Pollution Res Int 15:394-404.
38. Seiler A, Visan A, Buesen R, et al. 2004. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod Toxicol 18:231-240.
39. Spence S, Anderson C, Cukierski M, Patrick D. 1999. Teratogenic effects of the endothelin receptor antagonist L-753,037 in the rat. Reprod Toxicol 13:15-29.
40. Spielmann H. 2005. Predicting the risk of developmental toxicity from in vitro assays. Toxicol Appl Pharmacol 207:S375-S380.
41. Spielmann H, Genschow E, Scholz G, et al. 2001. Preliminary results of the ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 29:301-303.
42. Spielmann H, Liebsch M. 2001. Lessons learned from validation of in vitro toxicity test: From failure to acceptance into regulatory practice. Toxicol In Vitro 15:585-590.
43. Spielmann H, Pohl I, Doering B, et al. 1997. The embryonic stem cell test, an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicol 10:119-127. (Pubitemid 27234596)
44. Steele CE, New DA, Ashford A, Copping GP. 1983. Teratogenic action of hypolipidemic agents: An in vitro study with postimplantation rat embryos. Teratology 28:229-236. (Pubitemid 14227785)
45. Streisinger G, Walker C, Dower N, et al. 1981. Production of clones of homozygous diploid zebra fish (Brachydanio rerio). Nature 291:293-296.
46. Treinen KA, Louden C, Dennis MJ, Wier PJ. 1999. Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits. Teratology 59:51-59.
47. van Dartel DA, Pennings JL, Hendriksen PJ, et al. 2009. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate. Reprod Toxicol 2:93-102.
48. Zhang CX, Panzica-Kelly J, Augustine- Rauch KA. Way forward essay on developmental toxicological assays: Current and future state of the science. ALTOX website. Way Forward Essays. 2009. Available at http://altox.org/ttrc/ toxicity-tests/repro-dev-tox/way-forward/augustine-rauch/
49. Zhang CX, Cao J, Panzica J, et al. Establishment of a statistical prediction model and abbreviated assay design for teratogenicity screening of compounds using rat whole embryo culture. Birth Defects Res. In press.
50. zur Nieden NI, Kempka G, Ahr HJ. 2004. Molecular multiple endpoint embryonic stem cell test-A possible approach to test for the teratogenic potential of compounds. Toxicol Appl Pharmacol 194:257-269.